The ImmunoVerse™ is a monthly podcast exploring the past, present and future of immunotherapy and delving into every intricacy of the body's immune system. Hosted by Moffitt Cancer Center President and CEO, Dr. Patrick Hwu, each episode highlights the trailblazing visionaries who are pushing boundaries in this ever-evolving, world-changing field.
All content for The ImmunoVerse™ is the property of Moffitt Cancer Center and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The ImmunoVerse™ is a monthly podcast exploring the past, present and future of immunotherapy and delving into every intricacy of the body's immune system. Hosted by Moffitt Cancer Center President and CEO, Dr. Patrick Hwu, each episode highlights the trailblazing visionaries who are pushing boundaries in this ever-evolving, world-changing field.
Targeting KRAS: A New Era for Pancreatic Cancer, ft. Dr. Elizabeth Jaffee
The ImmunoVerse™
22 minutes
3 months ago
Targeting KRAS: A New Era for Pancreatic Cancer, ft. Dr. Elizabeth Jaffee
Dr. Patrick Hwu welcomes Dr. Elizabeth Jaffee of Johns Hopkins, a renowned leader in cancer immunotherapy. Dr. Jaffee shares the personal and scientific journey that led her to tackle one of oncology’s toughest challenges: pancreatic cancer. From her early fascination with virology to pioneering the use of genetically modified tumor vaccines, she has pushed the boundaries of what’s possible in cancer prevention and treatment.
Dr. Jaffee also discusses efforts to use immunotherapy earlier — even preventively — and explores how AI and multi-modal data could revolutionize cancer risk prediction and early detection.
The ImmunoVerse™
The ImmunoVerse™ is a monthly podcast exploring the past, present and future of immunotherapy and delving into every intricacy of the body's immune system. Hosted by Moffitt Cancer Center President and CEO, Dr. Patrick Hwu, each episode highlights the trailblazing visionaries who are pushing boundaries in this ever-evolving, world-changing field.